- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Zeo ScientifiX, Inc.: ZEO ScientifiX Launches Physician-Focused Masterclass Ahead of Florida's SB-1768 Law Implementation | 149 | ACCESS Newswire | FORT LAUDERDALE, FL / ACCESS Newswire / June 24, 2025 / ?ZEO ScientifiX, Inc.?("ZEO" or the "Company") (OTCQB:ZEOX), a clinical-stage biopharmaceutical company pioneering the research and development... ► Artikel lesen | |
| Di | Zeo ScientifiX, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 16.06. | Zeo ScientifiX, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 16.05. | Zeo ScientifiX, Inc. - S-1/A, General form for registration of securities | 3 | SEC Filings | ||
| 12.05. | Zeo ScientifiX, Inc. - 8-K, Current Report | - | SEC Filings | ||
| ZEO SCIENTIFIX Aktie jetzt für 0€ handeln | |||||
| 02.04. | Zeo ScientifiX, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 17.03. | Zeo ScientifiX, Inc. - 10-Q, Quarterly Report | 6 | SEC Filings | ||
| 18.02. | Zeo ScientifiX, Inc.: ZEO ScientifiX Strengthens Leadership Team With The Appointment of Dr. Peter Everts as Chief Scientific and Technology Officer | 299 | ACCESS Newswire | FORT LAUDERDALE, FL / ACCESS Newswire / February 18, 2025 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") (OTCQB:ZEOX), a clinical-stage biopharmaceutical company focused on the research and development... ► Artikel lesen | |
| 18.02. | Zeo ScientifiX, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 11.02. | ZEO ScientifiX, Inc.: ZEO ScientifiX Provides Business Update to Stockholders and the Investment Community | 268 | ACCESS Newswire | FORT LAUDERDALE, FL / ACCESS Newswire / February 11, 2025 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") (OTCQB:ZEOX), a clinical-stage biopharmaceutical company focused on the research and development... ► Artikel lesen | |
| 10.02. | Zeo ScientifiX, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 29.01. | Zeo ScientifiX, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 13.11.24 | ZEO ScientifiX, Inc.: ZEO ScientifiX and Exotropin Join Forces to Launch a Solution to Address the Growing Unmet Need for Hair Loss | 274 | ACCESS Newswire | FORT LAUDERDALE, FL / ACCESSWIRE / November 13, 2024 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") (OTCQB:ZEOX), a South Florida-based clinical-stage biopharmaceutical company, announced it has partnered... ► Artikel lesen | |
| 15.10.24 | Zeo ScientifiX, Inc.: ZEO ScientifiX, a Leading South Florida Biotechnology Company, Launches Regenerative Medicine Educational Series for Physicians | 227 | ACCESS Newswire | Events Hosted By ZEO ScientifiX Offer Providers Practical Business Tools Along With Science And Research Insights FORT LAUDERDALE, FL / ACCESSWIRE / October 15, 2024 / ZEO ScientifiX, Inc. ("ZEO" or... ► Artikel lesen | |
| 01.10.24 | Zeo ScientifiX, Inc.: ZEO ScientifiX Partners with National Provider of Healthcare Services | 242 | ACCESS Newswire | Physicians Group, LLC's Network Of Clinics And Diverse Patient Population Will Provide ZEO With Exclusive Research-Based OpportunitiesFORT LAUDERDALE, FL / ACCESSWIRE / October 1, 2024 / ZEO ScientifiX... ► Artikel lesen | |
| 24.09.24 | Zeo ScientifiX, Inc.: ZEO ScientifiX is Moving Toward Its Goal of Transforming Healthcare Through Leading-Edge Research | 307 | ACCESS Newswire | South Florida Biotech Company Seeks To Expand Its Research Program Into Phase 2 Clinical TrialsFORT LAUDERDALE, FL / ACCESSWIRE / September 24, 2024 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") (OTCQB:ZEOX)... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 40,885 | -0,28 % | Minimale Kursveränderung bei Qiagen NV-Aktie (40,55 €) | Am Aktienmarkt ist der Anteilsschein von Qiagen NV gegenwärtig unauffällig. Das Wertpapier kostete zuletzt 40,55 Euro. Der heutige Börsentag brachte bislang wenig Kursbewegung bei der Aktie von Qiagen... ► Artikel lesen | |
| ARTELO BIOSCIENCES | 14,650 | +106,92 % | Artelo Biosciences Announces Positive First-in-Human Data for ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain | First Orally Active Fatty Acid Binding Protein 5 Inhibitor Evaluated in Humans First-in-Class Approach Targets Unmet Need in Multibillion-Dollar Pain Management Market SOLANA BEACH, Calif., June 30... ► Artikel lesen | |
| EVOTEC | 7,204 | +0,92 % | Aktienmarkt: Evotec-Aktie kann sich nicht behaupten (6,38 €) | An der deutschen Börse liegt das Wertpapier von Evotec aktuell im Minus. Das Wertpapier notiert zur Stunde bei 6,38 Euro. Am Aktienmarkt liegt die Aktie von Evotec gegenwärtig im Minus. Die Aktie verbilligte... ► Artikel lesen | |
| SPRINGWORKS THERAPEUTICS | 46,995 | 0,00 % | SpringWorks Therapeutics, Inc. - 8-K, Current Report | ||
| BIONTECH | 90,60 | -0,71 % | Die nächste Cashcow? Schnelle Prozente mit NetraMark, Moderna, BioNTech | Erinnern Sie sich noch an den Impfstoff-Wettlauf in der Corona-Zeit? Damals bestimmte das Duell zwischen BioNTech und Curevac auch das Geschehen an der Börse. Anleger der ersten Stunde machten schnell... ► Artikel lesen | |
| ONCO-INNOVATIONS | 1,460 | +6,57 % | CEO von Onco-Innovations hält am Mittwoch, den 2. Juli 2025 eine Sondertelefonkonferenz für Investoren ab | Vancouver, Kanada - 25. Juni 2025 / IRW-Press / Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" oder das "Unternehmen") freut sich bekannt zu geben... ► Artikel lesen | |
| MODERNA | 23,810 | +2,17 % | Moderna-Aktie stabil nach Bestätigung des Market Perform-Ratings durch William Blair | ||
| RECURSION PHARMACEUTICALS | 5,095 | +1,29 % | Recursion Pharmaceuticals: Recursion Reports First Quarter 2025 Financial Results and Provides Business Update | Pipeline: Delivered on our commitment to a more focused R&D strategy by advancing a streamlined portfolio of 5+ clinical and preclinical programs in oncology and rare disease, while deprioritizing... ► Artikel lesen | |
| VOR BIOPHARMA | 1,630 | +56,73 % | Pre-market Movers: Vor Biopharma, Worthington Steel, Surf Air Mobility, Nano Labs, Protagenic Therapeutics | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.30 A.M. ET).In the Green Vor Biopharma Inc. (VOR) is up over 109% at $1.16.
Worthington... ► Artikel lesen | |
| VERVE THERAPEUTICS | 11,305 | -0,04 % | BMO downgrades Verve Therapeutics saying Lilly buyout deal caps upside | ||
| ADMA BIOLOGICS | 18,300 | +0,77 % | Will Strong Asceniv Sales Drive ADMA Biologics Further? | ||
| ARS PHARMACEUTICALS | 17,170 | -5,74 % | Raymond James reiterates strong buy on ARS Pharmaceuticals stock | ||
| ARCELLX | 65,45 | +1,02 % | Arcellx, Inc.: Arcellx Announces Its Participation at TD Cowen's 6th Annual Oncology Innovation Summit and Its Investor Event During EHA2025 | Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 20,940 | +1,60 % | Revolution Medicines, Inc.: Revolution Medicines and Summit Therapeutics Enter into Clinical Collaboration to Evaluate Combinations of Three RAS(ON) Inhibitors with Ivonescimab in RAS Mutant Tumors | REDWOOD CITY, Calif. and MIAMI, June 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with... ► Artikel lesen | |
| CUREVAC | 4,572 | -0,65 % | BioNTech schluckt CureVac! Evotec und Vidac als nächstes? Kurstreiber Übernahme und Kaufempfehlung | Steht bei Vidac Pharma eine neue Kursexplosion bevor? Im vergangenen Herbst ging es um rund 200 % nach oben. Gestern gab es eine Kaufempfehlung. Die Analysten sehen bei der Biotech-Perle Vervielfachungspotenzial.... ► Artikel lesen |
Das Unternehmen ZEO SCIENTIFIX INC kann der Branche Biotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ZEO SCIENTIFIX INC finden Sie auf Wallstreet Online.